Trevena
TRVN
#10609
Rank
$0.01 M
Marketcap
$0.01200
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -$31.06 Million USD

According to Trevena's latest financial reports the company's current earnings are $0.54 Million USD. In 2023 the company made an earning of -$36.33 Million USD, an increase over its 2022 earnings that were of -$52.42 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$31.06 Million-14.51%
2023 -$36.33 Million-30.69%
2022 -$52.42 Million1.38%
2021 -$51.71 Million78.04%
2020 -$29.04 Million21.3%
2019 -$23.94 Million-13.91%
2018 -$27.81 Million-59.75%
2017 -$69.09 Million-31.77%
2016 -$0.11 Billion101.73%
2015 -$50.2 Million1.14%
2014 -$49.64 Million114.83%
2013 -$23.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$8.24 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$0.76 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-$62.8 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-$0.63 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-$10.29 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-$79.39 Million 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA